Antiplatelet Therapies: Recent Advances in the Development of Platelet Glycoprotein IIb/IIIa Antagonists.
This article reviews recent advances in antiplatelet therapies, compares the antiplatelet/antithrombotic efficacy of various antiplatelet strategies to that of platelet glycoprotein (GP) IIb/IIIa receptor antagonists, and discusses issues in the development of long-term anti-GP IIb/IIIa therapy, and the potential adjunct strategies with GP IIb/IIIa antagonists.
Mousa
SA
DuPont Pharmaceuticals Company, Route 141 S. Henry Clay Road, Exp Station, E400/3470, Wilmington, DE 19880, USA.